Scrotum and testicular calcinosis in juvenile dermatomyositis (jdm). a report of two cases

Clinical and Experimental Rheumatology

Volumn 27, Issue 2, 2009, Pages 382-383

  Sallum, A M E ^a   Garcia, A J M ^a   Saito, O C ^a   Silva, C A A ^a  

^a Pediatric Rheumatology Unit   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; COLCHICINE; CYCLOSPORIN; DILTIAZEM; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE; THALIDOMIDE;

ADOLESCENT; CALCINOSIS; CASE REPORT; CHILD; DISEASE SEVERITY; ECHOGRAPHY; HUMAN; JUVENILE DERMATOMYOSITIS; LETTER; MALE; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCROTUM DISORDER; SKIN DISEASE; TESTIS DISEASE; THERAPY DELAY;

ADOLESCENT; CALCINOSIS; CHILD; DERMATOMYOSITIS; HUMANS; MALE; SCROTUM; TESTICULAR DISEASES;

EID: 67249096749     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (14)

1. REED AM. LOPEZ M: Juvenile dermatomyositis: recognition and treatment. Paediatr Drugs 2002; 4: 315-21.
2. SOGABE T. SILVA CAA. KISS MHB: Clinical and laboratory characteristics of 50 children with der-mato/polymyositis. Rev Bras Reumatol 1996; 36: 351-8.
3. SALLUM AME, KISS MHB, SACHETTI S et al.: Juvenile dermatomyositis: clinical, Iaboratorial, his-tological, therapeutical and evolutive parameters of 35 patients. Arq Neuropsiquiat 2002; 60: 889-99.
4. RIDER L: Childhood myositis: newly recognized diversity. In PLOTZ P (moderator): Myositis: im-munologic contributions to understanding cause. pathogenesis, and therapy. Ann Intern Med 1995; 122:715-24.
5. RIDER L: Calcinosis in Juvenile Dermatomyositis: Pathogenesis and Current Therapies. Pediatr Rheu-matol Online J 2003; 1 : 119-33.
6. SALLUM AM, PIVATO FC. PAIM LB, LEONE C, LIPHAUS BL, SILVA CA: Risk factors of calcinosis in juvenile dermatomyositis. Arthritis Rheum 2003; S513: 1302.
7. BOHAN A, PETER JB: Polymiositis and dermatomyositis. NEnglJMed 1975; 13: 344-7.
8. LOVELL DJ, LINDSLEV CB, RENNEBOHM RM et al.: Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 1999; 42: 2213-9.
9. BODE RK, KLEIN-GITELMAN MS, MILLER ML, LECHMAN TS. PACHMAN LM: Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum 2003; 49: 7-15.
10. FISLER RE, LIANG MG. FUHLBRIGGE RC, YAL-CINDAG A, SUNDEL. RP: Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 2002; 47: 505-11.
11. JALLEH RP, SWIFT RI, SUNDARESAN M, TOMA A, WOOD CB: Necrotising testicular vasculitis associated- with dermatomyositis. BrJUrol 1990; 66: 660.
12. BARKER RA, CURRIE DC, HORWICH A, SPIRO SG: Metastatic non-seminomatous germ cell tumour and dermatomyositis. Postgrad Med J 1990; 66: 59-60.
13. HAYAMI S, KUBOTA Y, SASAGAWA I, SUZUKI H, NAKADA T, MOTOYAMA T: Dermatomyositis associated with intratubular germ cell tumor and metastatic germ cell cancer. J Urol 1998; 159: 2096-7.
14. KIM W, ROSEN MA, LANGER JE. BANNER MP, SIEGELMAN ES, RAMCHANDANI P: US MR imaging correlation in pathologic conditions of the scrotum. Radiographics 2007; 27: 1239-53. 383